340 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter https://www.fool.com/investing/2017/05/22/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?source=iedfolrf0000001 May 22, 2017 - Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
Is Ironwood's Growth About to Slow? https://www.fool.com/investing/general/2017/06/05/is-ironwoods-growth-about-to-slow.aspx?source=iedfolrf0000001 Jun 05, 2017 - New competition could slow prescription growth for Linzess and take some of the luster off this small-cap biotech stock.
These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now https://www.fool.com/investing/2017/07/26/these-2-pharma-giants-may-be-on-pfizers-ma-radar-r.aspx?source=iedfolrf0000001 Jul 26, 2017 - Pfizer seems to be edging closer to a megadeal.
Restaurants scrambling after popular Saint Agnes Baking Co. pulls plug on bread business http://www.startribune.com/business/469830213.html Jan 18, 2018 - Restaurant owners are especially worried about losing their vendor with little notice with the expected Super Bowl rush.
Allergan's Irritable Bowel Drug Viberzi Approved in Canada http://www.zacks.com/stock/news/260911/allergans-irritable-bowel-drug-viberzi-approved-in-canada?cid=CS-ZC-FT-260911 May 17, 2017 - Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
Allergan Plc (AGN) Q1 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4071181-allergan-plc-agn-q1-2017-results-earnings-call-transcript?source=feed_sector_healthcare May 09, 2017 - Allergan Plc (NYSE:AGN)Q1 2017 Earnings CallMay 09, 2017 8:30 am ETExecutivesDaphne Karydas - Allergan PlcBrenton L. Saunders - Allergan PlcWilliam J. Meury - Allergan PlcC. David Nicholson - Allergan
The Top Earnings Charts to Start the Week http://www.zacks.com/stock/news/259797/the-top-earnings-charts-to-start-the-week?cid=CS-ZC-FT-259797 May 08, 2017 - With so many companies reporting earnings, Tracey wades through all the noise to bring you the best charts.
Should Gilead Sciences Be Worried About Allergan? https://www.fool.com/investing/2017/04/23/should-gilead-sciences-be-worried-about-allergan.aspx?source=iedfolrf0000001 Apr 23, 2017 - Gilead Sciences might want to pay attention to Allergan's aggressive expansion of its NASH program.
Here's Why Synergy Pharmaceuticals Inc. Is Falling Today https://www.fool.com/investing/2017/08/10/heres-why-synergy-pharmaceuticals-inc-is-falling-t.aspx?source=iedfolrf0000001 Aug 10, 2017 - Shares tumble after the company reports a higher-than-expected loss in the second quarter.
3 Top Healthcare Stocks to Buy Now https://www.fool.com/investing/2017/08/24/3-top-healthcare-stocks-to-buy-now.aspx?source=iedfolrf0000001 Aug 25, 2017 - This year's healthcare rally hasn't swept these quality stocks along with the rest of the sector. At least not yet.

Pages: 1234567...34

<Page 2>